Abstract
Introduction
Accumulation of saturated fatty acids in the kidney is associated with obesity-related glomerulopathy, including glomerular hyperfiltration, tubulointerstitial inflammation, proximal tubular cell apoptosis, and renal fibrosis [1] [2] [3] . Obesity-related inflammation and adipokine deregulation is responsible for kidney function, as demonstrated in rodent models [4] . Clinical studies have also indicated a direct relationship between obesity and renal complications [5] , and an association between the degree of obesity and chronic kidney disease [6] . Increased intrarenal levels of fatty acids can induce oxidative and endoplasmic reticulum stress (ERS), thus activation of the unfolded protein response and apoptosis [7] .
The 78-kDa glucose regulated protein (BIP), an ER resident chaperone, enhances newly synthesized folded proteins , decreases the accumulation of misfolded proteins, and promotes the ER-associated protein degradation which is increased in obesity [3] . Deteriorated ERS activates protein kinase-like endoplasmic reticulum kinase and induces phosphorylation of eukaryotic initiation factor (eIF2α), resulting in up-regulated activating transcription factor 4 (ATF4) and the transcription factor, C/EBP homologous protein (CHOP), thus initiating cell apoptosis [8] . Excessive ERS induced by saturated fatty acid activates CHOP-mediated up-regulated apoptotic Bax, and down-regulates anti-apoptotic Bcl-2. Previous evidence has shown that activated ERS in the kidney of high-fat diet (HFD) mice induces renal injury related to podocytes, proximal tubule cell apoptosis, and mesangial cells [1, 3, 9] .
Plasma angiotensin II levels are elevated in obesity [10] , resulting in oxidative stress and apoptosis [11] . Angiotensin II is recognized to induce a range of injuries, such as fibrogenesis, oxidative stress, ERS, and apoptosis throughout angiotensin II receptor (AT1R). Cellular oxidative stress induced by activation of the AT1R can be reversed by oral AT1 receptor blocker in the β-cell line, MIN6 [12] , and mice lacking AT1R exhibit attenuation of diet-induced obesity and insulin resistance [13] , indicating that AT1R plays a key role in obesity-induced renal injury.
Glucagon-like peptide-1(GLP-1), a gut incretin hormone, is used for type 2 diabetes and obesity. GLP-1 can decrease hyperglycemia, improve beta cell growth, reduce food intake and body weight [14] , and has anti-ERS effects [15] . A clinical study reported that patients with type 2 diabetes have significantly lower levels of the predominant circulating saturated free fatty acid following a GLP-1 subcutaneous infusion, with 2 kg of weight loss [16] . GLP-1 receptor (GLP-1R) has been confirmed to exist in the proximal tubules based on mRNA and protein levels. The renoprotective effect of diabetic nephropathy and acute kidney injury by GLP-1 therapy is associated with inhibition of renal inflammation and oxidative stress rather than metabolic improvement [17] . Inhibition of dipeptidyl peptidase-4, thus cleaving GLP-1, is a renoprotective effect of cisplatin-induced renal injury and rodent ischemia-reperfusion injury models through anti-inflammation and anti-apoptosis by lowering the mRNA expression ratios of Bax:Bcl-2 and Bim:Bcl-2 [18, 19] . GLP-1 has been shown to prevent apoptosis in diabetic kidney disease and ischemia-reperfusion injury models [18] . Whether or not this renoprotection is involved in the obesity-related renal disease inhibition of ERS and apoptosis by blocking AT1R is unclear. The present study was conducted to explore the effectiveness of GLP-1 on renal tubular ERS and apoptosis induced in mice fed HFD and palmitic acid (PA)-incubated HK2 cells, and to investigate the underlying mechanism.
Materials and Methods

Materials
PA, BSA, and GLP-1 were purchased from Sigma-Aldrich (St. Louis, MO, USA). Anti-CHOP, anti-BIP, anti-p-eIF2α/eIF2α, anti-ATF4, and anti-cleaved caspase 3 were purchased from Cell Signaling Technology (Beverly, MA, USA). Anti-AT1R, anti-sodium-glucose cotransporter 2 (SGLT2), Anti-Bcl-2, anti-Bax, anti-GAPDH, and anti-β-actin were from Abcam (Cambridge, MA,USA). Terminal deoxynucleotidyl transferasemediated dUTP-biotin nick end labeling (TUNEL) was obtained from Roche(Switzerland). The angiotensin II radioimmunoassay kit was bought from Mercodia (Uppsala, Sweden).
Animals
All animal procedures were reviewed and approved by the Institutional Animal Care and Use Committee at Fudan University (Shanghai, China). Six-week-old male C57BL/6 mice were obtained from the Experimental Animal Center of Fudan University and were housed on a 12 h light-dark cycle. The mice were fed with free access to standard rodent chow (10% of total calories from fat) and water or HFD (60% of total calories from fat) for 12 weeks. The mice were divided into three groups (n = 10 per group), as follows: control with standard diet (Con); high-fat diet group (HFD); and high-fat diet with GLP-1 treatment (HFDG). GLP-1 was administered subcutaneously (200 µg/kg, twice daily for 4 weeks). HFD received normal saline alone. Body weight and food intake were measured at 12 and 16 weeks. The food intake of ten mice in each group caged separately was measured for 5 days before intervention and at the end of the GLP-1 infusion. At week 16, all mice were anesthetized with pentobarbital, and the kidneys were rapidly excised.
Cell culture
The immortalized human proximal tubular cell line (HK2) was cultured in 60-mm dishes. HK2 was cultured in DMEM/F12, supplemented with 10% fetal bovine serum in an atmosphere of 5% CO 2 in air at 37°C. HK2 were starved overnight in culture medium without fetal bovine serum prior to treatment with PA (500 nM) or GLP-1(150 nM) for 24 h. HK2 cells with BSA served as controls. Then, HK2 were fixed by 4% paraformaldehyde for immunofluorescence or lysed with RIPA buffer and a protease inhibitor cocktail for western blotting. HK2 cells grown on glass cover slips in the different groups were stained with Hochest33258 and viewed by fluorescence microscopy for the measurement of apoptosis. An overexpression plasmid AT1R-pEX-3 containing the full-length AT1R gene transiently transfected into the HK2 cells was constructed by JK Genome Corporation, China.
Western blotting
The kidney tissues were homogenized and the supernatant was collected after centrifugation at 12,000 g for 20 min at 4°C. We separated the lysates on 10% polyacrylamide gels before immunoblotting. The protein concentrations of the tissues were detected by the BCA method (Beyotime, Shanghai, China). Protein samples were added in the SDS-PAGE gel and transferred to polyvinylidene difluoride membranes. Membranes were blocked for 1 h at room temperature with 3% bovine serum albumin. The membranes were incubated with the primary antibodies at a dilution of 1:1000. An ECL advance system (Amersham, Little Chalfont, UK) was used to analyze the membranes.
Immunohistochemistry and TUNEL
Kidney samples were fixed with 4% paraformalin for 24 h. After graded alcohol dehydration, kidney samples were embedded with paraffin, then cut in 4-μm sections for immunostaining of SGLT2, caspase 3, AT1R, and TUNEL. Tissue sections were dewaxed and rehydrated, then the antigens were unmasked by microwave pre-treatment in citrate buffer. Sections were blocked with 5% fetal bovine serum for 1 h at room temperature, then incubated overnight at 4°C with antibodies (1:200). Slides were rinsed in phosphate-buffered saline 3 times for 5 min and exposed to the secondary antibody for 1 h. Finally, slides were incubated with ABC complex for 30 min at 37°C and bound peroxidase activity was measured with DAB. Slides were imaged with a Nikon Eclipse 80i Epi-fluorescence microscope equipped with a digital camera (DS-Ri1; Nikon, Japan).
TUNEL assay was chosen to detect apoptotic cell death with a TUNEL system kit. Green-labeled TUNEL-positive cells were counted under 400×magnification in at least 10 random fields. The percentage of TUNEL-positive cells/total number of HK2 cells represented the apoptotic index. Blinding was implemented in all counting procedures.
Immunofluorescence HK2 cells were seeded onto sterile glass cover slips in 24-well dishes for 36 h. HK2 were treated with PA (500 nmol) and GLP-1(150 nM) for 24 h. Cells were fixed with 0.3 ml of 4% paraformaldehyde for 15 min prior to permeabilization in 0.25% Triton X-100 for 10 min at room temperature. Cells were blocked with 5% fetal bovine serum for 1 h at room temperature followed by incubation with primary and secondary antibodies. Primary antibodies were detected with fluorescence-labeled anti-mouse and anti-rabbit antibodies diluted 1:200 (Beyotime, Haimen, China). Nuclei were counterstained with 4',6-diamidino-2- phenylindole (DAPI,H-1200, Vector Laboratories, Burlingame, CA, USA) and were coverslipped on slides and imaged by a confocal fluorescent microscope (Nikon DS-Ri, Japan). Quantification was performed in a blinded manner. The AT1R immunofluorescence intensity was quantified by Image J software by measuring the positive staining area.
Statistical analyses
The results are expressed as the mean±SD. Data were analyzed by one-way ANOVA. A statistically significant difference was set at p<0.05.
Results
GLP-1 decreased food intake and ameliorated metabolic data
Food intake declined significantly in HFDG mice compared with HFD mice (42.8±9.7 vs. 56.9±8.1, p<0.05). The body weight and kidney weight in HFD mice were remarkably higher than Con mice at the end of the intervention. After GLP-1 treatment, the reduction in body and kidney weights were significantly compared with HFD mice (33.7±7.8g vs. 47.9±9.6g and 0.28±0.015g vs. 0.30±0.009g, respectively, p <0.05). Systolic blood pressure(SBP) was higher in HFD mice than Con mice (121±17.6 mmHg vs. 98±10.8 mmHg, p<0.05), and GLP-1 treatment significantly decreased SBP (106±19.8 mmHg), as shown in Fig. 1 .
GLP-1 attenuated renal tubular injury in HFD mice
The histologic findings of renal tubules were assessed through periodic acid-Schiff staining (PAS). Representative photomicrograghs illustrated vacuolated tubular cells completely filled in the cortex of the HFD mice. The vacuoles pushed the nucleus to the edge of the proximal tubular cells. Chronic GLP-1 treatment remarkably suppressed the development of vacuolated tubular cells, while the injury attenuated responses to GLP-1 treatment (Fig. 2A) . SGLT2 is mainly located in the brush border membrane of the proximal convoluted tubule of the kidney. SGLT2 expression was less extensive in HFD mice compared with Con mice, while SGLT2 expression in the proximal tubules was restored in HFDG mice as demonstrated by immunohistochemistry (Fig. 2B and C) and western blotting ( Fig. 2D  and E) .
As shown in Fig. 3 , western blotting demonstrated remarkably increased expression of BIP, p-eIF2α, ATF4, and CHOP proteins in the cortex of HFD mice compared to the Con group and GLP-1 decreased the increasing expression (p<0.05). The anti-apoptosis protein, Bcl-2, was inhibited in HFD mice compared with Con mice, while Bcl-2 was markedly increased in HFDG mice. Bax and cleaved caspase 3 were higher in HFD mice than Con mice; however, GLP-1 treatment inhibited all of the changes (p<0.05; Fig. 4A and B) . In the kidneys of Con mice, few positive cells of apoptosis were detected in the tubules. In HFD mice, HFD was associated with a significantly increased number of apoptotic cells in renal tubules compared with Con mice (Fig. 4C, 4D, 4E and F) . In contrast, apoptotic cells were markedly decreased when HFD mice were treated with GLP-1 (p<0.05). 
GLP-1 prevented HK2 cell ERS and apoptosis induced by PA
Incubation with PA increased ERS marker expression, including BIP, p-eIF2α, ATF4, and CHOP abundance, indicating that PA induced HK2 cell apoptosis. This was significantly prevented by GLP-1 ( Fig. 6A and B) . However, GLP-1 treatment could not prevent ERS from Tunicamycin in HK2 cells (Fig. 6C and D) . Increased Bax and cleaved caspase 3 protein in HK2 induced by PA was reduced after GLP-1 treatment (Fig. 7A and B) . The anti-apoptosis protein, Bcl-2, was improved by GLP-1 treatment after PA intervention. The percentage of HK2 cells containing TUNEL-positive nuclei markedly increased in HFD mice, which was attenuated significantly by GLP-1 treatment (Fig. 7C and D) .
GLP-1 blocked AT1R expression in HK2 cells induced by PA
Following incubation of HK2 cells with PA, AT1R expression was dramatically increased, as indicated by western blotting and immunofluorescence (Fig. 8 ). HK2 cells incubated by PA was associated with significantly increased AT1R expression relative to Con cells (p<0.05). The expression of AT1R was dramatically reduced with GLP-1 treatment compared to PAtreated cells.
However, GLP-1 treatment could not block AT1R expression and ameliorate apoptosis induced by up-regulation of AT1R with an over-expression plasmid AT1R-pEX-3 containing the full-length AT1R gene in PA-incubated HK2 cells (Fig. 9 ).
Discussion
The current study demonstrated the development and progression of HFD induced renal injury in mice, and GLP-1 treatment ameliorated the severity of injury related to increased SGLT2 expression, decreased ERS, and apoptosis. Also, GLP-1 treatment decreased the body weight with an accompanying reduction in food intake, and had a positive effect on SBP control. These findings were associated with a reduction in renal tubular AT1R expression.
The high-fat diet mouse model is characterized by hyperlipidemia and insulinemia as a result of obesity. Accumulating evidence demonstrated that obesity is associated with renal insufficiency in mice and humans [2, 3] . We found vacuolated tubular cells completely filled in the cortex of the HFD mice in PAS and less extensive SGLT2 expressed in HFD mice compared with Con mice in the proximal tubule demonstrated by immunohistochemistry and western blotting. SGLT2 is located only in the apical brush border of the S1 and S2 portion of the proximal renal tubule. The SGLT2 reabsorbs approximately 90% of the filtered glucose load. Loss of expression of SGLT2 restricts renal function [20] . Decreased SGLT2 expression in HFD mice indicated that HFD induced proximal renal tubule injury, while GLP-1 treatment attenuated the disorder. Fatty acids have been proved to activate ERS in animal and human mesangial cells, podocytes, proximal tubular cells, and the tubulointerstitium [3, 21, 22] . ERS contributed to the pathophysiology of renal injury according to aberrant metabolic conditions, such as hyperglycemia and hyperlipidemia [3] . Our data confirmed that HFD mice and HK2 cells incubated with PA had induced significant ERS markers, such as BIP, p-eIF2α, ATF4, and CHOP. Additionally, the CHOP-mediated activation of apoptotic pathways was related to up-regulated Bax and down-regulated Bcl-2, and increased expression of cleaved caspase 3 were involved in PA-induced tubule cells apoptosis both in vivo and in vitro. GLP-1R is produced in the pancreas, gut, hypothalamus, and kidney. Previous studies demonstrated that GLP-1R played an anti-apoptosis role in INS-1 cells [23] , H9c2 cells [24] and astrocytes [15] . GLP-1 binding to GLP-1R resulted in body weight loss due to decreased food intake. Weight loss improved metabolism relative to insulin sensitivity, hypertension, hyperlipidemia, and hyperglycemia [16] . The present study demonstrated the anti-hypertensive effects in HFDG mice followed by less AT1R expression. Blocking AT1R expression by valsartan decreases HFD-induced hypertension in mice [3] . Hence, we drew the conclusion that blocking AT1R expression by GLP-1 was responsible for the anti-hypertensive effects. The intake of abundant saturated fatty acids resulted in ERS in the intestines and decreased GLP-1 production [25] , suggesting that exogenous GLP-1 may reduce the injury. GLP-1 receptor analog remarkably decreased markers of inflammation, oxidative stress, and fibrosis in the kidneys of maternal obesity mice [26] . GLP-1 decreased BIP and p-eIF2α protection against ER stress-induced cell apoptosis-associated transcription receptor involved in activation of local renin-angiotensin system(RAS) in the kidney during increased fatty acid overload, which has been proved to induce kidney injury via ERS and apoptosis induced by saturated fatty acid infused in vitro and in vivo [3] . Serum angiotensin II levels significantly increased in HFD mice compared with controls while HFDG mice induced a higher level of angiotensin II than non-treated mice, but with no significant difference, which may be attributed to the blocked AT1R expression in HFDG mice. GLP-1 reversed glomerular endothelium cell injury through inhibition of angiotensin II signaling on cRaf (Ser259), supporting the view that GLP-1 primarily affected kidney physiology through inhibition of RAS activity in vitro [28] . In HFD and HK2 cells treated with PA, AT1R expression was inhibited after GLP-1 treatment. Previous studies reported that blocking AT1R prevents obesity-induced hypertension [3] , insulin resistance [29] , inflammation [29] , fatty liver, and fibrosis [30] in obese animal models. Up-regulation of AT1R with an over-expression plasmid AT1R-pEX-3 in PA-incubated HK2 cells induced apoptosis was not ameliorated by GLP-1 treatment, while reduced AT1R expression in HFDG mice compared to HFD mice indicated GLP-1 treatment may exert renoprotective effects of saturated fatty acid-induced kidney tubular cell ERS and apoptosis, at least partly, by inactivation local RAS with blocking AT1R expression in vivo and in vitro. Healthy human treatment with a 2-h GLP-1 infusion appeared as a rapid decrease in plasma angiotensin II concentration, whereas renin, aldosterone, and the urinary excretion of angiotensinogen showed no significant changes [31] . This acute effect of GLP-1 on plasma angiotensin II concentration may not be in parallel to long-term GLP-1 infusion in mice, while the potential relationship between GLP-1 and AT1R warrant further study. GLP-1 analogues are potentially useful for protecting against the detrimental effects in mice exposed to a high fat diet on renal. One clinical study with a focus on obesity indicated that a GLP-1 infusion reduced the glomerular filtration rate from 151 to 142 ml/min, as measured by creatinine clearance [32] , while more clinical studies are needed to validate the encouraging results.
Guo et al.: GLP-1 Ameliorates Renal Injury
Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry
